Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer Peptide Vaccine Therapy Developed from Oncoantigens Identified through Genome-wide Expression Profile Analysis for Bladder Cancer

25 May 2012

Abstract excerpt

OBJECTIVE: The field of cancer vaccine therapy is currently expected to become the fourth option in the treatment of cancer after surgery, chemotherapy and radiation therapy. We developed a novel cancer peptide vaccine therapy for bladder cancer through a genome-wide expression profile analysis. METHODS: Among a number of oncoproteins that are transactivated in cancer cells, we focused on M phase phosphoprotein 1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Immunotherapy and Immune Responses
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22636067
DOI: 10.1093/jjco/hys069

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer Peptide Vaccine Therapy Developed from Oncoantigens Identified through Genome-wide Expression Profile Analysis for Bladder CancerPMID 22636067Read ↗

Reversing the "cold" tumor microenvironment: the role of neoantigen vaccines in prostate cancer.Semantic proximity Read ↗

Screening of tumor antigens and immunogenic cell death landscapes of prostate cancer for exploration of mRNA vaccineSemantic proximity Read ↗

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read ↗

Insilico Identification of MHC displayed Tumor Associated Peptides in Ovarian Cancer for Multi-Epitope Vaccine ConstructSemantic proximity Read ↗

Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.Semantic proximity Read ↗

Latest progress in molecular biology and treatment in genitourinary tumours.Semantic proximity Read ↗

Therapeutic Effects of a Neoantigen Vaccine With an Immune Checkpoint Inhibitor in a Cisplatin-Treated Mouse ModelSemantic proximity Read ↗

Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatmentSemantic proximity Read ↗

Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.Semantic proximity Read ↗

DNA vaccines for the treatment of prostate cancerSemantic proximity Read ↗

FOXM1 / DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapySemantic proximity Read ↗

Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.